Your browser doesn't support javascript.
loading
Clinical and Pharmacological Considerations for Concomitant Administration of Posaconazole and Isavuconazole with Letermovir.
Terrier, Jean; Zanella, Marie-Céline; Masouridi-Levrat, Stavroula; Kronig, Ilona; Chalandon, Yves; Vernaz, Nathalie; Van Delden, Christian; Papanicolaou, Genovefa; Neofytos, Dionysios.
  • Terrier J; Division of Clinical Pharmacology and Toxicology Service, Geneva University Hospitals, Geneva, Switzerland.
  • Zanella MC; Division of General Internal Medicine, Geneva University Hospitals, Geneva, Switzerland.
  • Masouridi-Levrat S; Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland.
  • Kronig I; Hematology Division, Oncology Department, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • Chalandon Y; Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland.
  • Vernaz N; Hematology Division, Oncology Department, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • Van Delden C; Medical Directorate, Finance Directorate, Geneva University Hospitals, University of Geneva, Geneva, Switzerland.
  • Papanicolaou G; Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland.
  • Neofytos D; Infectious Diseases Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Article en En | MEDLINE | ID: mdl-33782007

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Antifúngicos Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Antifúngicos Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Año: 2021 Tipo del documento: Article